Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide ...

Wegovy, Trulicity and similar prescription drugs — originally designed for treatment of Type 2 diabetes — but now used widely as weight loss medications, including by millions of people without ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to the hundreds of millions of people grappling with obesity. When combined ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Starting January 1, the cost of the popular weight loss medication Wegovy will drop significantly in Israel—but only for its lower doses. Here's what this means for patients, how much you'll ...

The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased interest around obesity ...

The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster ...